RA

Ruben Abagyan

MO Molsoft: 2 patents #3 of 21Top 15%
University of California: 2 patents #4,561 of 18,278Top 25%
NU New York University: 1 patents #708 of 1,640Top 45%
NM New York University School Of Medicine: 1 patents #6 of 33Top 20%
The General Hospital: 1 patents #1,411 of 3,021Top 50%
UM University Of Massachusetts: 1 patents #755 of 1,810Top 45%
Overall (All Time): #793,265 of 4,157,543Top 20%
6
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
11919880 HCV protease inhibitors Ittipat Meewan 2024-03-05
11834450 Compounds having ((3-nitrophenyl)sulfonyl)acetamide as BCL-2 inhibitors Volodymyr Kysil, Vladislav Zenonovich Parchinsky, Alexei Pushechnikov, Alexandre Vasilievich Ivachtchenko, Andrew Orry +2 more 2023-12-05
11697650 Compounds having tetrahydroindolizine-1-carboxamide as BCL-2 inhibitors Volodymyr Kysil, Vladislav Zenonovich Parchinsky, Alexei Pushechnikov, Alexandre Vasilievich Ivachtchenko, Andrew Orry +2 more 2023-07-11
9737525 Small molecule activators of NRF2 pathway Aleksey G. Kazantsev, Leslie Thompson, Malcolm Casale 2017-08-22
8961987 Immunogen comprising the HIV GP120 V3 loop in a conformation that induces broadly neutralizing antibodies Susan Zolla-Pazner, Miroslaw K. Gorny, Timothy Cardozo, Xiang-peng Kong, Maxim Totrov +2 more 2015-02-24
8394811 Hydrazide compounds as thyroid hormone receptor modulators and uses thereof Herbert Samuels, Matthieu Schapira, Maxim Totrov, Bruce M. Raaka, Stephen R. Wilson +2 more 2013-03-12